CEROOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as CEROW
CERO THERAPEUTICS HOLDINGS, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.01+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $253.05K
- P/E (TTM)
- –
- Dividend yield
- 172833.33%
Share price
−$1.9840 (−99.70%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Jun 30, 2026
Valuation
- Market cap
- $253.05K
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- 172833.33%
- Free cash flow yield
- –
Fundamentals
- Net income
- -$16.31M
- Book value per share
- -$0.72
- Diluted shares
- 42M
Five years at a glance
Fiscal years 2021 to 2025 and trailing twelve months, USD
Operating income
–
Net income
-$16.31M
EPS, diluted
–
Reported periodTrailing twelve months